AKER Insider Trading Activity and SEC Form 4 Filings
AKER insider trading summary
No open-market insider purchases or sales of Akers Biosciences, Inc. (AKER) have been reported on SEC Form 4 in the past 12 months.
Latest AKER insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 28, 2020 | Hudson Bay Capital Management LP | 10% Owner | Sell | $2K (638 @ $2.81) |
| Feb 28, 2020 | Sander Gerber | 10% Owner | Sell | $2K (638 @ $2.81) |
| Feb 27, 2020 | Hudson Bay Capital Management LP | 10% Owner | Sell | $42K (15,300 @ $2.72) |
| Feb 27, 2020 | Sander Gerber | 10% Owner | Sell | $42K (15,300 @ $2.72) |
| Feb 25, 2020 | Hudson Bay Capital Management LP | 10% Owner | Sell | $38K (13,000 @ $2.92) |
| Feb 25, 2020 | Sander Gerber | 10% Owner | Sell | $38K (13,000 @ $2.92) |
| Dec 20, 2019 | Sander Gerber | 10% Owner | Buy | $24K (8,000 @ $3.02) |
| Dec 20, 2019 | Hudson Bay Capital Management LP | 10% Owner | Buy | $24K (8,000 @ $3.02) |
| Dec 19, 2019 | Hudson Bay Capital Management LP | 10% Owner | Buy | $8K (2,700 @ $3.08) |
| Dec 19, 2019 | Sander Gerber | 10% Owner | Buy | $8K (2,700 @ $3.08) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.